| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 07:31:24 UTC |
|---|
| Update Date | 2022-11-30 19:26:32 UTC |
|---|
| HMDB ID | HMDB0116241 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | CDP-DG(i-17:0/18:2(9Z,11Z)) |
|---|
| Description | CDP-DG(i-17:0/18:2(9Z,11Z)) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(i-17:0/18:2(9Z,11Z)), in particular, consists of one chain of isoheptadecanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05% or so of the total phospholipids). |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCC(C)C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCC\C=C/C=C\CCCCCC InChI=1S/C47H83N3O15P2/c1-4-5-6-7-8-9-10-11-12-13-16-20-23-26-29-32-43(52)63-39(35-60-42(51)31-28-25-22-19-17-14-15-18-21-24-27-30-38(2)3)36-61-66(56,57)65-67(58,59)62-37-40-44(53)45(54)46(64-40)50-34-33-41(48)49-47(50)55/h9-12,33-34,38-40,44-46,53-54H,4-8,13-32,35-37H2,1-3H3,(H,56,57)(H,58,59)(H2,48,49,55)/b10-9-,12-11-/t39-,40-,44+,45?,46-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Isoheptadecanoyl-2-(9Z,11Z)-octadecadienoyl-sn-glycero-3-CDP | HMDB | | 1-Isoheptadecanoyl-2-(9Z,11Z)-octadecadienoyl-sn-glycero-3-cytidine-5'-diphosphate | HMDB | | CDP-DG(I-17:0/18:2) | HMDB | | CDP-DG(I-17:0/18:2N7) | HMDB | | CDP-DG(I-17:0/18:2W7) | HMDB | | CDP-DG(35:2) | HMDB | | CDP-Diacylglycerol(I-17:0/18:2(9Z,11Z)) | HMDB | | CDP-Diacylglycerol(I-17:0/18:2) | HMDB | | CDP-Diacylglycerol(I-17:0/18:2N7) | HMDB | | CDP-Diacylglycerol(I-17:0/18:2W7) | HMDB | | CDP-Diacylglycerol(35:2) | HMDB | | {[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(15-methylhexadecanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinate | HMDB | | CDP-DG(i-17:0/18:2(9Z,11Z)) | SMPDB |
|
|---|
| Chemical Formula | C47H83N3O15P2 |
|---|
| Average Molecular Weight | 992.135 |
|---|
| Monoisotopic Molecular Weight | 991.529942981 |
|---|
| IUPAC Name | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(15-methylhexadecanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid |
|---|
| Traditional Name | [(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy([hydroxy((2R)-3-[(15-methylhexadecanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy)phosphoryl]oxy)phosphinic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCC(C)C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCC\C=C/C=C\CCCCCC |
|---|
| InChI Identifier | InChI=1S/C47H83N3O15P2/c1-4-5-6-7-8-9-10-11-12-13-16-20-23-26-29-32-43(52)63-39(35-60-42(51)31-28-25-22-19-17-14-15-18-21-24-27-30-38(2)3)36-61-66(56,57)65-67(58,59)62-37-40-44(53)45(54)46(64-40)50-34-33-41(48)49-47(50)55/h9-12,33-34,38-40,44-46,53-54H,4-8,13-32,35-37H2,1-3H3,(H,56,57)(H,58,59)(H2,48,49,55)/b10-9-,12-11-/t39-,40-,44+,45?,46-/m1/s1 |
|---|
| InChI Key | YHAIELFAJVDDQF-VAKFDSNKSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cdp-diacylglycerols. These are glycerolipids containing a diacylglycerol, with a cytidine diphosphate attached to the oxygen O1 or O2 of the glycerol part. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | CDP-glycerols |
|---|
| Direct Parent | CDP-diacylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cdp-diacylglycerol
- Pyrimidine ribonucleoside diphosphate
- Diacyl-glycerol-3-pyrophosphate
- Pentose phosphate
- Pentose-5-phosphate
- Glycosyl compound
- N-glycosyl compound
- Monosaccharide phosphate
- Organic pyrophosphate
- Fatty acid ester
- Monoalkyl phosphate
- Hydroxypyrimidine
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Hydropyrimidine
- Pyrimidine
- Phosphoric acid ester
- Monosaccharide
- Organic phosphoric acid derivative
- Heteroaromatic compound
- Tetrahydrofuran
- Carboxylic acid ester
- 1,2-diol
- Secondary alcohol
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Organopnictogen compound
- Organic oxide
- Alcohol
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayDisease pathway- Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0043519)
- Cardiolipin Biosynthesis CL(a-13:0/i-19:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0047710)
- Cardiolipin Biosynthesis CL(i-12:0/a-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0050289)
- Cardiolipin Biosynthesis CL(i-12:0/i-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0052875)
- Cardiolipin Biosynthesis CL(i-12:0/i-19:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0053522)
- Cardiolipin Biosynthesis CL(i-13:0/a-21:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0056432)
- Cardiolipin Biosynthesis CL(i-13:0/a-25:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0056759)
- Cardiolipin Biosynthesis CL(i-13:0/i-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0058704)
- Cardiolipin Biosynthesis CL(i-14:0/a-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0061353)
- Cardiolipin Biosynthesis CL(i-14:0/a-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0061626)
- Cardiolipin Biosynthesis CL(i-14:0/i-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0062167)
- Cardiolipin Biosynthesis CL(a-13:0/a-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0043841)
- Cardiolipin Biosynthesis CL(a-13:0/i-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0045774)
- Cardiolipin Biosynthesis CL(a-13:0/i-14:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0046096)
- Cardiolipin Biosynthesis CL(i-12:0/a-21:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0050611)
- Cardiolipin Biosynthesis CL(i-12:0/a-25:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0050935)
- Cardiolipin Biosynthesis CL(i-12:0/i-12:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0051260)
- Cardiolipin Biosynthesis CL(i-12:0/i-18:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0053199)
- Cardiolipin Biosynthesis CL(i-13:0/a-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0055461)
- Cardiolipin Biosynthesis CL(i-13:0/a-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0055784)
- Cardiolipin Biosynthesis CL(i-13:0/i-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0057404)
- Cardiolipin Biosynthesis CL(i-13:0/i-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0058061)
- Cardiolipin Biosynthesis CL(i-13:0/i-16:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0058383)
- Cardiolipin Biosynthesis CL(i-13:0/i-19:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0059377)
- Cardiolipin Biosynthesis CL(i-13:0/i-20:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0059705)
- Cardiolipin Biosynthesis CL(i-13:0/i-21:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0060037)
- Cardiolipin Biosynthesis CL(i-14:0/a-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0061026)
- Cardiolipin Biosynthesis CL(i-14:0/i-14:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0062490)
- Cardiolipin Biosynthesis CL(i-14:0/i-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0063426)
- Cardiolipin Biosynthesis CL(a-13:0/a-25:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0045132)
- Cardiolipin Biosynthesis CL(a-13:0/i-12:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0045454)
- Cardiolipin Biosynthesis CL(a-13:0/i-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0046420)
- Cardiolipin Biosynthesis CL(a-13:0/i-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0047066)
- Cardiolipin Biosynthesis CL(a-13:0/i-20:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0048031)
- Cardiolipin Biosynthesis CL(a-13:0/i-24:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0048997)
- Cardiolipin Biosynthesis CL(i-12:0/a-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0049642)
- Cardiolipin Biosynthesis CL(i-12:0/a-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0049965)
- Cardiolipin Biosynthesis CL(i-12:0/i-14:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0051907)
- Cardiolipin Biosynthesis CL(i-12:0/i-22:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0054491)
- Cardiolipin Biosynthesis CL(i-12:0/i-24:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0054812)
- Cardiolipin Biosynthesis CL(i-13:0/18:2(9Z,11Z)/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0055136)
- Cardiolipin Biosynthesis CL(i-13:0/a-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0056108)
- Cardiolipin Biosynthesis CL(a-13:0/a-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0044164)
- Cardiolipin Biosynthesis CL(a-13:0/a-17:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0044485)
- Cardiolipin Biosynthesis CL(a-13:0/a-21:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0044809)
- Cardiolipin Biosynthesis CL(a-13:0/i-16:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0046742)
- Cardiolipin Biosynthesis CL(a-13:0/i-18:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0047387)
- Cardiolipin Biosynthesis CL(a-13:0/i-21:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0048351)
- Cardiolipin Biosynthesis CL(a-13:0/i-22:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0048675)
- Cardiolipin Biosynthesis CL(i-12:0/18:2(9Z,11Z)/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0049320)
- Cardiolipin Biosynthesis CL(i-12:0/i-13:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0051584)
- Cardiolipin Biosynthesis CL(i-12:0/i-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0052230)
- Cardiolipin Biosynthesis CL(i-12:0/i-16:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0052552)
- Cardiolipin Biosynthesis CL(i-12:0/i-20:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0053844)
- Cardiolipin Biosynthesis CL(i-12:0/i-21:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0054169)
- Cardiolipin Biosynthesis CL(i-13:0/i-12:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0057082)
- Cardiolipin Biosynthesis CL(i-13:0/i-14:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0057737)
- Cardiolipin Biosynthesis CL(i-13:0/i-18:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0059048)
- Cardiolipin Biosynthesis CL(i-13:0/i-22:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0060376)
- Cardiolipin Biosynthesis CL(i-13:0/i-24:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0060699)
- Cardiolipin Biosynthesis CL(i-14:0/i-12:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0061844)
- Cardiolipin Biosynthesis CL(i-14:0/i-15:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0062819)
- Cardiolipin Biosynthesis CL(i-14:0/i-16:0/i-17:0/18:2(9Z,11Z)) (PathBank: SMP0063153)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 9.81 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 24.3406 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.85 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4696.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 159.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 327.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 189.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 911.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1420.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1210.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 296.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2497.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1162.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2330.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 981.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 655.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 139.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 243.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.6 seconds | 40023050 |
Predicted Kovats Retention IndicesNot Available |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-13 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 10V, Positive-QTOF | splash10-03di-0920000101-025e58d7dd274de41f1b | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 20V, Positive-QTOF | splash10-03di-1920000000-b0b7c91fab638b14e830 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 40V, Positive-QTOF | splash10-03di-3931000100-ec6ab3dbb6e88413688a | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 10V, Negative-QTOF | splash10-0o90-0690000303-dbaf88f95cba0fa927f2 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 20V, Negative-QTOF | splash10-0i00-5692200201-25625d051b4b3c66ede7 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 40V, Negative-QTOF | splash10-0bvi-5921000000-3fd512ed5ecc84694a4b | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 10V, Positive-QTOF | splash10-0006-9100010038-8a6859ad76150bc72db7 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 20V, Positive-QTOF | splash10-0aor-7100000069-61d45685836e4fe6cba4 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 40V, Positive-QTOF | splash10-01b9-0014900000-7a3693c2e76b19951194 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 10V, Negative-QTOF | splash10-0006-0000000109-5f1fa2072b1b264efec3 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 20V, Negative-QTOF | splash10-02bf-9070800501-329cf2e29ac4036d405e | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(i-17:0/18:2(9Z,11Z)) 40V, Negative-QTOF | splash10-0api-8449601202-7bebca2629ccdd0b5dfa | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|